Article

Identification and Exploration of Serine Peptidase Inhibitor Kazal Type 1 (SPINK1) as a Potential Biomarker Correlated with the Progression of Non-Small Cell Lung Cancer

2020-03-24

Abstract excerpt

<title>Abstract</title> <p>Background Lung cancer is one of the most common malignancies worldwide and is the leading cause of cancer-related death. Approximately 85% of lung cancer patients represent a group of histological subtypes collectively known as non-small cell lung cancer (NSCLC).Methods To explore the molecular mechanisms underlying tumorigenesis and progression of NSCLC, mRNA expression profiles were...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2540a7f9-f665-54ed-b77d-d61915e3d680
DOI: 10.21203/rs.3.rs-18387/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification and Exploration of Serine Peptidase Inhibitor Kazal Type 1 (SPINK1) as a Potential Biomarker Correlated with the Progression of Non-Small Cell Lung CancerDOI 10.21203/rs.3.rs-18387/v1Read

Functional Roles of SPINK1 in Cancers.Semantic proximity Read

PLEK2 and SCN7A: novel biomarkers of non-small cell lung cancerSemantic proximity Read

Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular CarcinomaSemantic proximity Read

WNT inhibitor SP5-mediated SERPING1 suppresses lung adenocarcinoma progression via TSC2/mTOR pathwaySemantic proximity Read

Comprehensive Analysis of PSME2 and Its Significant Role in Non- small cell lung cancerSemantic proximity Read

PLEK2 promotes lung adenocarcinoma progression via activating the PI3K/AKT signaling pathway through SPC25 Running title: PLEK2 promotes LUAD via SPC25/PI3K/AKT axisSemantic proximity Read

Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.Semantic proximity Read

Analysis of the effect of NEKs on the prognosis of patients with Non-small-cell lung carcinoma based on bioinformaticsSemantic proximity Read

PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25Semantic proximity Read

Pan-cancer analysis reveals potential for synergy between SERPINA1 molecular targeting and macrophage-related immunotherapySemantic proximity Read

Upregulation of microRNA-483-5p Advances Non-small Cell Lung Cancer (NSCLC) Progression via Stifling HIPK2 ExpressionSemantic proximity Read